S1P effect on cIAP2 knockout mice microglia during EAE, an animal model of multiple sclerosis Srikethan Mahavadi.

Slides:



Advertisements
Similar presentations
3rd International Conference on Neurology & Therapeutics
Advertisements

The Role of Aryl Hydrocarbon Receptor (AhR) in the Immune System of Aging Mice Duy Pham Dr. Nancy I. Kerkvliet Department of Environmental and Molecular.
T cell-mediated immunity Chapter 8
Multiple Sclerosis (MS) Presented By: Alyssa Sturm & Brittany Gray December 4, 2012.
Determining the Role of GPX, an antixodant, in the Inflammatory Changes Associated with Emphysema Navida Bholanauth Dr. Jeanine D’Armiento Columbia University.
BY PROF. AZZA EL-MEDANY DR. OSAMA YOUSIF General Features & Conditions to use antirheumatic Low doses are commonly used early in the course of the disease.
ENDOCANNABINOID REGULATION OF ALTERNATIVE MICROGLIA ACTIVATION IN MULTIPLE SCLEROSIS CAITLIN JAGLA.
Modulation of NF ‐ κB ‐ dependent transcription and cell survival by the SIRT1 deacetylase by Fan Yeung, Jamie E Hoberg, Catherine S Ramsey, Michael D.
Free Powerpoint Templates Page 1 Free Powerpoint Templates What is the IL gene family —Creative BioMart.
Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease  C Bjartmar, J.R Wujek, B.D Trapp  Journal of.
Gamma-aminobutyric acid (GABA) treatment blocks inflammatory pathways and promotes survival and proliferation of pancreatic beta cells Gérald J. Prud’homme,
Modulation of Gene Expression via Disruption Of NF-kB Signaling by a
M1 – Immunology CYTOKINES AND CHEMOKINES March 26, 2009 Ronald B
M1 – Immunology EFFECTOR T CELL FUNCTIONS (Part I) March 27, 2009 Ronald B. Smeltz, Ph.D. Microbiology and Immunology
EUN JOO LEE M.D, Ph.D.1. Woo Tack Kim, M.D., Ph.D.2
Rachel Miller BNFO 300 Spring 2017
Research, 2016, Vol. 4, No. 1, doi: /jfnr-4-1-6
Mononuclear phagocytes in Immune Defence
Rachel Miller BNFO 300 Spring 2017
Epigallocatechin-3-Gallate Inhibits Matrix Metalloproteinase-9 and Monocyte Chemotactic Protein-1 Expression Through the 67-κDa Laminin Receptor and the.
Biologic therapy of inflammatory bowel disease
T cell mediated immunity Part II
Pharmacological inhibition of caspase-8 suppresses inflammation-induced lymphangiogenesis and allograft rejection in the cornea  Wenru Su, MD, PhD, Longhui.
Figure 5 Dendritic cells in liver inflammation
Syk Mediates IL−17-Induced CCL20 Expression by Targeting Act1-Dependent K63- Linked Ubiquitination of TRAF6  Nan-Lin Wu, Duen-Yi Huang, Hsin-Ni Tsou, Ying-Cing.
Cell Signaling.
The relevance of animal models in multiple sclerosis research
Statins for all: the new premed?
Toll-like receptors: Applications to dermatologic disease
Biologic therapy of inflammatory bowel disease
Figure 3 Molecular mechanisms of crystal-induced necroinflammation
ROS Function in Redox Signaling and Oxidative Stress
Whipping NF-κB to Submission via GADD45 and MKK7
Tumor necrosis factor: Biology and therapeutic inhibitors
Roles for Chemokines in Liver Disease
How Attenuation Of Microglial Cell Using Cre-Lox Can Effect Pathology of EAE Induce Mice By Kevin Limlengco.
Volume 8, Issue 3, Pages (March 1998)
Volume 9, Issue 3, Pages (March 2004)
The Two Faces of Receptor Interacting Protein Kinase-1
Nat. Rev. Nephrol. doi: /nrneph
Interleukin-33 in Tissue Homeostasis, Injury, and Inflammation
Figure 4 TNFSF inflammatory activities in tissue cells
Mechanisms of immune escape in the tumor microenvironment.
Figure 3 Current model of immunopathogenesis in CIDP
Tilo Biedermann, Martin Röcken, José M. Carballido 
Diana Panayotova-Dimitrova, Maria Feoktistova, Martin Leverkus 
Experimental Hematology
Anti-inflammatory Agents: Present and Future
Killing Lymphoma with Smac-Mimetics: As Easy as ABC?
Mechanisms Underlying Inflammation in Neurodegeneration
An Inflammatory Perspective on Necroptosis
Inflammation and Lipid Signaling in the Etiology of Insulin Resistance
Volume 18, Issue 4, Pages (April 2010)
Functional Diversity and Regulation of Different Interleukin-1 Receptor-Associated Kinase (IRAK) Family Members  Sophie Janssens, Rudi Beyaert  Molecular.
Volume 43, Issue 6, Pages (December 2015)
Multiple Sclerosis is a neurological, immune-mediated disorder
Figure 4 Bile-acid-induced TGR5 signalling pathways in macrophages
Christoph Becker, Alastair J. Watson, Markus F. Neurath 
Figure 3 Underlying mechanisms of TREG cells in atherosclerosis
Autoimmune Disease and miRNAs
Cell-mediated immunity Regulation of the immune response
Components and outcomes of selected TNF-superfamily signalling pathways. Components and outcomes of selected TNF-superfamily signalling pathways. (Left)
Functional Diversity and Regulation of Different Interleukin-1 Receptor-Associated Kinase (IRAK) Family Members  Sophie Janssens, Rudi Beyaert  Molecular.
Table 1. Bioactive properties in Coriolus versicolor
Moutih Rafei, Elena Birman, Kathy Forner, Jacques Galipeau 
NK cell immune evasion occurs through loss of TNF pathway members.
NF-κB Regulation by NLRs: T Cells Join the Club
Tumor necrosis factor: Biology and therapeutic inhibitors
by Gonghua Huang, Yanyan Wang, Peter Vogel, and Hongbo Chi
Cytokines and cytokine receptors involved in type I immunity in tuberculosis. Cytokines and cytokine receptors involved in type I immunity in tuberculosis.
Presentation transcript:

S1P effect on cIAP2 knockout mice microglia during EAE, an animal model of multiple sclerosis Srikethan Mahavadi

Multiple Sclerosis Autoimmune disease of the CNS Demyelination, axonal degeneration, and cell death More common in women than men Women are 2-3 times more likely to be diagnosed with MS Loss of motor skills, vision loss Experimental Autoimmune Encephalomyelitis (EAE) is the mouse experimental model of MS

Microglia Glial cells which function as immune cells of the CNS Secrete cytokines such as TNF-  and IL-1 These are both signaling proteins involved in inflammation and regulation of immune cells Cytokines are small proteins that have an effect on other cells in this case immune cells

TNF Signaling Pathway

cIAP2 E3 ubiquitin ligase necessary to activate NF-kB pathway When cIAP is bound, the cell is thought to be saved from apoptosis Lippopolysaccharide (LPS) treated cIAP2- /- mice survived better than wildtype mice cIAP2-/- mice exhibited high inflammation and exaggerated symptoms of EAE , TNF was highly expressed

Previous Experiments

Experimental Questions Why is every cell but microglia dying? Is S1P being released, which is saving microglia?

Sphingosine-1-phosphate (S1P) S1P is a lipid mediator involved in extracellular signaling A study done by Cuviller et al. shows that S1P prevents the features of apoptosis. It is believed that S1P is secreted by dead cells S1P is present at elevated levels in the CNS during inflammation

Experiment Overview Cell Line: Microglia from mice Control Group: cells treated with no inflammatory cytokines or S1P Experimental Group: cells treated with TNF-,, TNF- and S1P, S1P Inflammatory cytokines added 30 min prior to S1P and incubated for 24 hours Cytotoxicity measured in 490 nm plate reader

LDH-Cytotoxicity LDH is an enzyme found in all living cells which catalyzes the conversion of lactate to pyruvate as well as NAD+ to NADH. An enzyme transfers NADH to NAD+ and reduce WST to formazan(a salt) which shows up orange

LDH Cytotoxicity

Possible Outcomes Cytotoxicity levels go down as the S1P is increasing the survival of microglia Cytotoxicity levels go up as the S1P is not changing the survival of microglia Possible Further Experiments would include identifying if the S1P is working on the DISC complex or elsewhere or even doing the same experiment and inhibiting the R4 receptor Limitations

Discussion How exactly is S1P increasing the survival of microglia when inflammatory cytokines are released? Can S1P be further used as drug therapy for patients with MS?

References Yester, J. W., Bryan, L., Waters, M. R., Mierzenski, B., Biswas, D. D., Gupta, A. S., . . . Kordula, T. (2015). Sphingosine-1-phosphate inhibits IL-1–induced expression of C-C motif ligand 5 via c-Fos–dependent suppression of IFN-β amplification loop. The FASEB Journal, 29(12), 4853-4865. doi:10.1096/fj.15- 275180 What Is MS? (n.d.). Retrieved from https://www.nationalmssociety.org/What-is-MS Constantinescu, C. S., Farooqi, N., Obrien, K., & Gran, B. (2011). Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS). British Journal of Pharmacology, 164(4), 1079-1106. doi:10.1111/j.1476-5381.2011.01302.x Silke, J., & Meier, P. (2013). Inhibitor of Apoptosis (IAP) Proteins-Modulators of Cell Death and Inflammation. Cold Spring Harbor Perspectives in Biology, 5(2). doi:10.1101/cshperspect.a008730 Conte, D., Holcik, M., Lefebvre, C. A., Lacasse, E., Picketts, D. J., Wright, K. E., & Korneluk, R. G. (2005). Inhibitor of Apoptosis Protein cIAP2 Is Essential for Lipopolysaccharide-Induced Macrophage Survival. Molecular and Cellular Biology, 26(2), 699-708. doi:10.1128/mcb.26.2.699-708.2006 Chen, G. (2002). TNF-R1 Signaling: A Beautiful Pathway. Science,296(5573), 1634-1635. doi:10.1126/science.1071924 Cuvillier, O., Pirianov, G., Kleuser, B., Vanek, P. G., Coso, O. A., Gutkind, J. S., & Spiegel, S. (1996). Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature, 381(6585), 800-803. doi:10.1038/381800a0 Dojindo Molecular Technologies (2012). LDH Cytotoxicity Assay